<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT2016110124635N5</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2016-12-06</date_registration>
      <primary_sponsor>Ahvaz Jundishapur University of Medical ُSciences</primary_sponsor>
      <public_title>Transcranial direct current stimulation for chronic tinnitus treatment</public_title>
      <acronym></acronym>
      <scientific_title>Clinical trial of comparison of effects of long term bifrontal anodal, cathodal, and sham treatment of  transcranial direct current stimulation on tinnitus symptoms in patients with chronic idiopathic drug resistant tinnitus</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2016-03-01</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>75</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/20769</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment.</study_design>
      <phase>N/A</phase>
      <hc_freetext>chronic tinnitus.</hc_freetext>
      <i_freetext>Intervention 1: Anodal intervention group (n=25): Treatment protocol consists of daily one session (2 mA for 20 min with 35 cm2 electrode), 5 consecutive sessions per week for two consecutive weeks (10 sessions) where anode is placed at left dorsolateral prefrontal cortex (DLPFC) and cathode at right DLPFC. Intervention 2: Cathodal intervention group (n=25): Treatment protocol consists of daily one session (2 mA for 20 min with 35 cm2 electrode), 5 consecutive sessions per week for two consecutive weeks (10 sessions) where anode is placed at right dorsolateral prefrontal cortex (DLPFC) and cathode at left DLPFC. Intervention 3: Sham treatment (n=25): Treatment protocol is the same as anodal treatment, but after 40-50 sec the device will be turned OFF without informing the patients.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan></results_IPD_plan>
      <results_IPD_description></results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Ali Yadollahpour</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Bioelectromagnetic Clinic, Ahvaz Imam Khomeini Hospital, Azadegan St.</address>
        <city>Ahvaz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>6135715794</zip>
        <telephone>+966 13 222 2925</telephone>
        <email>yadollahpour.a@gmail.com</email>
        <affiliation>Bioelectromagnetic Clinic, Ahvaz Imam Khomeini Hospital, Ahvaz Jundishapur University of Medical Sci</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Ali Yadollahpour</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Bioelectromagnetic Clinic, Ahvaz Imam khomeini Hospital, Azadegan St.</address>
        <city>Ahvaz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>6193673166</zip>
        <telephone>+98 61 3222 2925</telephone>
        <email>yadollahpour.a@gmail.com</email>
        <affiliation>Bioelectromagnetic Clinic, Ahvaz Imam Khomeini Hospital, Ahvaz Jundishapur University of Medical Sci</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Inclusion criteria: chronic tinnitus for more than 6 months; resistance to medications; idiopathic tinnitus. Exclusion criteria: history of seizure attacks; high blood pressure; pace maker; brain trauma; severe psychiatric disorders.</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>70 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria></exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>H93.1</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>chronic tinnitus</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Devices</i_code>
      <i_code>Treatment - Devices</i_code>
      <i_code>Placebo</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Anodal intervention group (n=25): Treatment protocol consists of daily one session (2 mA for 20 min with 35 cm2 electrode), 5 consecutive sessions per week for two consecutive weeks (10 sessions) where anode is placed at left dorsolateral prefrontal cortex (DLPFC) and cathode at right DLPFC.</i_keyword>
      <i_keyword>Cathodal intervention group (n=25): Treatment protocol consists of daily one session (2 mA for 20 min with 35 cm2 electrode), 5 consecutive sessions per week for two consecutive weeks (10 sessions) where anode is placed at right dorsolateral prefrontal cortex (DLPFC) and cathode at left DLPFC.</i_keyword>
      <i_keyword>Sham treatment (n=25): Treatment protocol is the same as anodal treatment, but after 40-50 sec the device will be turned OFF without informing the patients.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>ُTinnitus Handicap Inventory (THI) Score. Timepoint: Pre intervention, Post intervention at one hour after last transcranial direct current stimulation (tDCS) session and at one month after last tDCS session. Method of measurement: THI questionnaire.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Tinnitus intensity. Timepoint: Prior and post each transcranial direct current stimulation (tDCS) session (5 min after end of session), one week, and one month after last tDCS session. Method of measurement: Numerical rating scale (0 to 10).</sec_outcome>
      <sec_outcome>Tinnitus distress. Timepoint: Prior and post each transcranial direct current stimulation (tDCS) session (5 min after end of session), one week, and one month after last tDCS session. Method of measurement: Numerical rating scale (0 to 10).</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Ahvaz Jundishapur University of Medical ُSciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2016-02-13</approval_date>
        <contact_name>Ethical research committee, Ahvaz Jundishapur University of Medical Sciences</contact_name>
        <contact_address>Deputy of Research, Ahvaz Jundishapur University of Medical Sciences, Golestan Blv.. Ahvaz  Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
